GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Walvax Biotechnology Co Ltd (SZSE:300142) » Definitions » Cyclically Adjusted FCF per Share

Walvax Biotechnology Co (SZSE:300142) Cyclically Adjusted FCF per Share : ¥-0.13 (As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is Walvax Biotechnology Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Walvax Biotechnology Co's adjusted free cash flow per share for the three months ended in Mar. 2025 was ¥-0.149. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥-0.13 for the trailing ten years ended in Mar. 2025.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 21.70% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 11.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Walvax Biotechnology Co was 21.70% per year. The lowest was 10.90% per year. And the median was 16.30% per year.

As of today (2025-06-01), Walvax Biotechnology Co's current stock price is ¥10.33. Walvax Biotechnology Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was ¥-0.13. Walvax Biotechnology Co's Cyclically Adjusted Price-to-FCF of today is .


Walvax Biotechnology Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Walvax Biotechnology Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Walvax Biotechnology Co Cyclically Adjusted FCF per Share Chart

Walvax Biotechnology Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.24 -0.25 -0.23 -0.17 -0.12

Walvax Biotechnology Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.17 -0.17 -0.15 -0.12 -0.13

Competitive Comparison of Walvax Biotechnology Co's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Walvax Biotechnology Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Walvax Biotechnology Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Walvax Biotechnology Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Walvax Biotechnology Co's Cyclically Adjusted Price-to-FCF falls into.


;
;

Walvax Biotechnology Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Walvax Biotechnology Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.149/115.1156*115.1156
=-0.149

Current CPI (Mar. 2025) = 115.1156.

Walvax Biotechnology Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -0.097 99.500 -0.112
201509 -0.048 100.500 -0.055
201512 -0.056 100.600 -0.064
201603 -0.114 102.200 -0.128
201606 -0.097 101.400 -0.110
201609 -0.071 102.400 -0.080
201612 0.031 102.600 0.035
201703 -0.085 103.200 -0.095
201706 -0.064 103.100 -0.071
201709 -0.027 104.100 -0.030
201712 -0.055 104.500 -0.061
201803 -0.068 105.300 -0.074
201806 -0.037 104.900 -0.041
201809 -0.040 106.600 -0.043
201812 -0.046 106.500 -0.050
201903 -0.050 107.700 -0.053
201906 -0.077 107.700 -0.082
201909 0.016 109.800 0.017
201912 -0.077 111.200 -0.080
202003 -0.085 112.300 -0.087
202006 -0.050 110.400 -0.052
202009 0.034 111.700 0.035
202012 -0.087 111.500 -0.090
202103 -0.185 112.662 -0.189
202106 -0.095 111.769 -0.098
202109 -0.052 112.215 -0.053
202112 0.078 113.108 0.079
202203 -0.096 114.335 -0.097
202206 0.017 114.558 0.017
202209 0.107 115.339 0.107
202212 0.044 115.116 0.044
202303 -0.029 115.116 -0.029
202306 -0.020 114.558 -0.020
202309 0.136 115.339 0.136
202312 0.030 114.781 0.030
202403 -0.143 115.227 -0.143
202406 0.009 114.781 0.009
202409 0.206 115.785 0.205
202412 0.233 114.893 0.233
202503 -0.149 115.116 -0.149

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Walvax Biotechnology Co  (SZSE:300142) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Walvax Biotechnology Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Walvax Biotechnology Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Walvax Biotechnology Co Business Description

Traded in Other Exchanges
N/A
Address
Kexin Road, No. 395, High-tech Zone, Yunnan Province, Kunming, CHN, 650101
Walvax Biotechnology Co Ltd is engaged in research and development, production and sales of vaccine products.
Executives
Wu Yun Yan Executives
Zhao Jin Long Executives
Yao Wei Executives
Zhou Hua Executives
Shi Jing Executives
Jiang Run Sheng Directors, executives
Gong Sun Qing Executives
Executives
Yuan Lin Executives
Fang Guo Liang Executives
Li Yun Chun Director
Huang Zhen Director
Zhang Li Secretary Dong
Yang Hong Wei Supervisors
Xu Ke Ren Executives

Walvax Biotechnology Co Headlines

No Headlines